Differential changes in axonal conduction following CNS demyelination in two mouse models

Authors

  • Yoshio Bando,

    1. Department of Functional Anatomy and Neuroscience, Asahikawa Medical College, Midorigaoka-Higashi 2-1-1-1, Asahikawa, Hokkaido 078-8510, Japan
    Search for more papers by this author
    • *

      Y.B. and K.T. contributed equally to this work.

  • Kaoru Takakusaki,

    1. Department of Physiology, Division of Neural Function, Asahikawa Medical College, Midorigaoka-Higashi 2-1-1-1, Asahikawa, Hokkaido 078-8510, Japan
    Search for more papers by this author
    • *

      Y.B. and K.T. contributed equally to this work.

  • Shinji Ito,

    1. Department of Functional Anatomy and Neuroscience, Asahikawa Medical College, Midorigaoka-Higashi 2-1-1-1, Asahikawa, Hokkaido 078-8510, Japan
    Search for more papers by this author
  • Ryuji Terayama,

    1. Department of Functional Anatomy and Neuroscience, Asahikawa Medical College, Midorigaoka-Higashi 2-1-1-1, Asahikawa, Hokkaido 078-8510, Japan
    2. Department of Oral Function and Anatomy, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Okayama 700-8525, Japan
    Search for more papers by this author
  • Makoto Kashiwayanagi,

    1. Department of Physiology, Division of Neural Function, Asahikawa Medical College, Midorigaoka-Higashi 2-1-1-1, Asahikawa, Hokkaido 078-8510, Japan
    Search for more papers by this author
  • Shigetaka Yoshida

    1. Department of Functional Anatomy and Neuroscience, Asahikawa Medical College, Midorigaoka-Higashi 2-1-1-1, Asahikawa, Hokkaido 078-8510, Japan
    Search for more papers by this author

Dr Y. Bando, as above.
E-mail: ybando@asahikawa-med.ac.jp

Abstract

Transgenic and disease model mice have been used to investigate the molecular mechanisms of demyelinating diseases. However, less attention has been given to elucidating changes in nerve conduction in these mice. We established an experimental system to measure the response latency of cortical neurons and examined changes in nerve conduction in cuprizone-induced demyelinating mice and in myelin basic protein-deficient shiverer mice. Stimulating and recording electrodes were placed in the right and left sensori-motor cortices, respectively. Electrical stimulation of the right cortex evoked antidromic responses in left cortical neurons with a latency of 9.38 ± 0.31 ms (= 107; mean ± SEM). While response latency was longer in mice at 7 days and 4 weeks of cuprizone treatment (12.35 ± 0.35 ms, = 102; 11.72 ± 0.29 ms, = 103, respectively), response latency at 7 days and 4 weeks after removal of cuprizone was partially restored (10.72 ± 0.45 ms, = 106; 10.27 ± 0.34 ms, = 107, respectively). Likewise, electron microscopy showed cuprizone-induced demyelination in the corpus callosum and nearly complete remyelination after cuprizone removal. We also examined whether the myelin abnormalities in shiverer mice affected their response latencies. But there were no significant differences in response latencies in shiverer (9.83 ± 0.24 ms, = 103) and wild-type (9.33 ± 0.22 ms, = 112) mice. The results of these electrophysiological assessments imply that different demyelinating mechanisms, differentially affecting axon conduction, are present in the cuprizone-treated and shiverer mice, and may provide new insights to understanding the pathophysiology of demyelination in animal models in the CNS.

Ancillary